FDA.reportPublic FDA data

drospirenone 0.25 MG / estradiol 0.5 MG Oral Tablet

RxCUI
1483549
RxNorm name
drospirenone 0.25 MG / estradiol 0.5 MG Oral Tablet
Display name
drospirenone 0.25 MG / estradiol 0.5 MG Oral Tablet
Full name
drospirenone 0.25 MG / estradiol 0.5 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:04

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AngeliqDROSPIRENONE AND ESTRADIOLBayer HealthCare Pharmaceuticals Inc.761834c2-6b61-4583-84c2-f1ca4a97c4f22026-03-02Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1483549

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
761834c2-6b61-4583-84c2-f1ca4a97c4f2drospirenone 0.25 MG / estradiol 0.5 MG Oral TabletPSN20These highlights do not include all the information needed to use ANGELIQ safely and effectively. See full prescribing information for ANGELIQ. ANGELIQ (drospirenone and estradiol) tablets, for oral use Initial U.S. Approval: 200520260302
761834c2-6b61-4583-84c2-f1ca4a97c4f2drospirenone 0.25 MG / estradiol 0.5 MG Oral TabletSCD20These highlights do not include all the information needed to use ANGELIQ safely and effectively. See full prescribing information for ANGELIQ. ANGELIQ (drospirenone and estradiol) tablets, for oral use Initial U.S. Approval: 200520260302